Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.3110
-0.0501 (-13.87%)
At close: Jul 21, 2026, 4:00 PM EDT
0.3400
+0.0290 (9.32%)
After-hours: Jul 21, 2026, 7:49 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $995.46 thousand as of July 21, 2026. Its market cap has decreased by -71.95% in one year.
Market Cap
995.46K
Enterprise Value
10.81M
1-Year Change
-71.95%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $995.46K, a decrease of -97.93%. That is a compound annual growth rate of -56.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 995.46K | -72.82% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.48M |
| Azitra | 2.38M |
| Calidi Biotherapeutics | 2.25M |
| CDT Equity | 2.21M |
| Bone Biologics | 2.03M |
| Matinas BioPharma Holdings | 1.86M |
| VivoSim Labs | 1.73M |
| Biodexa Pharmaceuticals | 1.70M |